Back to Journals » Drug Design, Development and Therapy » Volume 12

Original Research

HA/HSA co-modified erlotinib–albumin nanoparticles for lung cancer treatment

       
Total article views   HTML views PDF downloads Totals
15,583 Dovepress* 14,519+ 1,045 15,564
PubMed Central* 1,064 270 1,334
Totals 15,583 1,315 16,898
*Since 23 July 2018
Total mentioned Facebook Delicious Reddit Twitter Others
4 1 0 0 1 2

View citations on PubMed Central and Google Scholar